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Abstract 
Background: There are millions of people living with COPD who have not been diagnosed. 
Patients have regularly lost half of their lung function by the point of diagnosis, and 
therefore there are little interventions available. 
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Aim: The aim of this systematic literature review, was to identify factors influencing late- 
and under-diagnosis of COPD within primary care. This includes considering the current 
methods of COPD screening, and whether an early-screening would benefit diagnostic rates.  
Methods: A comprehensive, systematic literature search was undertaken using the 
following databases: BNI, CINAHL, Medline, NHS Evidence, PubMed, ScienceDirect, Wiley 
Online. Following this, a critical review of literature was performed on ten relevant articles. 
A thematic analysis followed. 
Results: There is a significant lack of up-to-date research on COPD screening and early 
detection. Generalised screening versus case-finding may be a method of identifying the 
undiagnosed population, however, evidence needs to improve. There is a lack of COPD 
education in healthcare and wider society. COPD amongst women is on the rise, yet they are 
less likely to be identified for COPD. 
Conclusion: The responsibility of increased diagnoses does not only lie with nurses, but with 
organisations. There is a necessity for up-to-date guidance and research to be provided. 
Screening is likely to be the future preferred method for identifying those undiagnosed, but 
research needs to identify the benefits of screening versus case-finding. 
Relevance: The findings can be applied to primary care nursing, to combat COPD 
underdiagnoses. 
 
Key Points 
• Early detection of COPD reduces mortality rates, and improves quality of life 
• Early detection can be achieved through generalised screening, but research needs 
to be undertaken to compare generalised screening with case-finding approaches 
• Education and nurse training must improve 
• Microspirometry must only be used as a precursor tool, and spirometry for diagnosis 
• Women are the at-risk population 
• There is a call for updated clinical guidelines regarding COPD screening 
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Introduction 
Chronic Obstructive Pulmonary Disease is commonly late, and/or under-diagnosed, 
particularly in the five years preceding diagnosis (NICE, 2016; Jones et al, 2014). COPD 
progression rates can be reduced and symptoms can be improved by early detection, as 
there are more management options available. Furthermore, early detection improves 
mortality and morbidity rates (Csikesz and Gartman, 2014), and improves patient outcomes 
(Garvey, 2016). In addition, patients can maintain a considerable quality of life for longer 
(National Institute for Health and Care Excellence (NICE), 2016). The interventions available 
for mild COPD following early diagnosis would save the NHS £1 billion over ten years 
(Department of Health (DoH), 2010). COPD screening using questionnaires and diagnostic 
spirometry, is achievable in primary care, and costs are deemed manageable (Dirven et al, 
2013). In addition, the cost of treatment for COPD further down the line is significantly 
greater. A study showed that COPD diagnosis two years earlier would have saved SEK 15 
billion (≈£1.37 billion) in healthcare costs for 600,000 patients (Larsson et al, 2016). Despite 
this, COPD is regularly underdiagnosed. Nurses play a pivotal role in the influence of the 
disease through early detection, accurate diagnosis, monitoring the disease progression, 
evidence-based treatment, and even prevention (Garvey, 2016).  
 
Background 
Chronic Obstructive Pulmonary Disease (COPD) is an incurable long-term condition 
(Department of Health (DoH), 2015). NICE (2011) suggests screening those aged 35 years 
and above, who are (ex)smokers, and have a chronic cough. This is known as case-finding, as 
it selects patients only who have certain symptoms and risk factors. However, patients are 
commonly missed using this method, as patients may be symptomless with mild-moderate 
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COPD (Kathirvel Senthilnathan et al, 2016). It is imperative to consider early detection as 
later down the line, patients have a reduced access to treatments, and smoking cessation 
makes considerably less of an impact upon lung function decline; this is likely due to the 
speed of lung decline following a sigmoid pattern through GOLD stages II and III before 
reaching advanced stages (Csikesz and Gartman, 2014). 
Within the field of respiratory medicine, there remains controversy regarding the 
population that should be screened for COPD (GOLD, 2017). Some argue that the screening 
of asymptomatic patients shows no benefit (Siu et al, 2016), particularly in those not 
exposed to risk factors (GOLD, 2017). These contend only screening symptomatic smokers 
or those exposed to risk factors (López Varela, 2016). On the other hand, other studies 
support screening asymptomatic smokers (Barthwal and Singh, 2014), or the general 
population (Nelson et al, 2012). Therefore, questions arise regarding screening itself. The 
current practice is active case-finding, not screening (GOLD, 2017), as case-finding in 
primary care is a practicable option in terms of resources, for early COPD detection (López 
Varela, 2016). But is this method responsible for the missing millions? 
 
 
Aims 
The aim of this systematic literature review, is to identify why COPD is late- and under-
diagnosed within primary care. This includes, comparing the benefits of case-finding versus 
general screening for COPD, and to ascertain if the two methods affect rates of COPD 
diagnosis. In addition, the role of the nurse in early COPD diagnosis in primary care will be 
considered. 
 
 
Methodology 
Studies pertaining to COPD screening in primary care were sought. The following databases 
were used: BNI, CINAHL, Medline, NHS Evidence, PubMed, ScienceDirect, Wiley Online. The 
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search was undertaken using keywords and Boolean expressions (Smith and Noble, 2015). 
Derivatives of the following search terms were used: “chronic obstructive pulmonary 
disease”; “screen*”; “nurs*”. 
Inclusion Criteria: Articles published within the past five years; free to access; peer-reviewed 
journal articles; published within the past five years; written in English; similar healthcare 
system to the UK; primary source. Results were further limited by hand-searching, omitting 
any articles less relevant to the topic. Following this, the most pertinent articles were 
selected, and the reference lists were investigated; selecting any applicable articles that met 
the inclusion criteria. This is known as snowball sampling: the selection of participants from 
earlier participants (Polit and Beck, 2017). A total of ten articles were selected. Following 
this, a systematic review of literature was undertaken. Caldwell et al’s (2011) critiquing 
framework was employed for all quantitative and qualitative articles. For mixed methods 
studies, MacInnes’s (2009) framework was utilised. Following this, the studies underwent a 
thematic analysis using a meta-matrix, to enable themes and patterns across the study to be 
identified (Polit and Beck, 2017). 
 
Results 
 
The Influence of Gender upon Diagnosis 
Chronic Obstructive Pulmonary Disease among women is on the rise (Csikesz and Gartman, 
2014; Aryal, Diaz and Mannino, 2014), and has now equalised between the genders (GOLD, 
2017 cite Landis et al, 2014; Wisnivesky et al, 2014). This is likely due to the increased 
prevalence of smoking among women (GOLD, 2017; Office for National Statistics, 2017; 
Delgado et al, 2016; Forey et al, 2011; Schirnhofer et al, 2007), or exposure to other risk 
factors, such as indoor pollution (GOLD, 2017; Schirnhofer et al, 2007). Other explanations 
could be women working in customarily male roles (Aryal, Diaz and Mannino, 2014), or due 
to physiological susceptibilities, such as increased airway hyperresponsiveness (GOLD, 2017 
cite Foreman et al, 2011; Blair and Evelo, 2013) and faster lung decline (Blair and Evelo, 
2013 cite Verhage et al, 2011).  
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Other evidence suggests that rising rates of COPD in women are likely to be a result of 
women’s greater incline to seek medical advice (Malmusi et al, 2014) and to partake in 
screening (Kotaki et al, 2017; Delgado et al, 2016; Weiss et al, 2014 Estes et al, 
2014)Menezes et al, 2005). Traditional gender roles saw men as the ‘stronger’ character. A 
study has showed that these stereotypes exist today in healthcare, with men more likely to 
be in denial about their diagnosis (p<0.01) due their assigned ‘strong’ gender role (Modica 
et al, 2014). Therefore, the participation rates of women in studies are often higher, which 
may result in a gender bias (Kotaki et al, 2017). On the other hand, women were found to be 
taken less seriously for signs of COPD, and labelled with psychosomatic symptoms, even 
when the severity of COPD between the two sexes was equal (Delgado et al, 2016). Men 
were more likely to be suspected of COPD by Family Practitioners (FPs), with women 
frequently receiving less therapeutic efforts, and male FPs referring male patients to 
specialists (Delgado et al, 2016). Therefore, gender inequality also exists among 
professionals, which affects the decision-making process. In a study of clinical practice, men 
were more likely to have suspected COPD (Roberts, Patel and Partridge, 2016), suggesting 
that women are more frequently underdiagnosed than men. 
 
The Obligation of Screening for Early Diagnosis  
The identification of COPD in healthcare remains at the centre of debate. Some studies 
support screening for COPD in the general population (Kotaki et al, 2017; Dirven et al, 2013; 
Sansores et al, 2013), or those who are asymptomatic smokers (Wisnivesky et al, 2014; Buist 
et al, 2005). Screening poses many benefits, out of those who are caught later, 50% of 
patients found to have COPD had no previous diagnosis, and by this point, there are very 
few interventions available (Wisnivesky et al, 2014). By the time patients are diagnosed with 
COPD, their FEV1<50% predicted (Blair and Evelo, 2013), meaning the patients have 
moderate to severe COPD (GOLD, 2017). UK national guidelines assert that COPD needs to 
be diagnosed early and accurately (Gruffydd-Jones et al, 2015). Wisnivesky et al (2014) 
support the screening of asymptomatic smokers, stating that it may identify those in the 
earlier stages of COPD, who remain undiagnosed. In addition, the authors state that 
asymptomatic patients can have moderate COPD, and patients caught earlier are more likely 
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to quit smoking. This is likely to be due to the ‘hope’ of slowed progression rate of COPD 
(Bragadottir et al, 2017).  
Others support case-finding only, where patients are screened for COPD based upon 
symptoms and risk factors (GOLD, 2017; López Varela et al, 2016; Estes et al, 2014; Weiss et 
al, 2014; Buist et al, 2005). NICE (2011) argue that case-finding is the most cost-effective 
method. Moreover, generalised screening generates a vast increase in workload that 
professionals may be unable to handle (Haroon et al, 2015). Staff and funding are often 
barriers to screening in primary care (Kotaki et al, 2017; Estes et al, 2014). Furthermore, 
pharmacological treatment has a poor impact on early COPD (Celli et al, 2015; NICE, 2011). 
In addition, asymptomatic individuals with COPD GOLD Grade I may not have a lower lung 
function than asymptomatic individuals without COPD (Celli et al, 2015 cite Bridevaux et al, 
2008).  
Sansores et al (2013) produced a pioneering study that compared the generalised screening 
of smokers against a case-finding cohort. The findings showed that undiagnosed COPD was 
far more prevalent in the screening group (13.3% vs. 10.1%). The authors state that despite 
GOLD (2011) guidelines, screening with spirometry may be useful for detecting smokers 
with COPD; particularly so in women who are more susceptible to the effects of smoking, 
and have a faster decline in lung function (Delgado et al, 2016). Furthermore, the PLATINO 
study discovered that underdiagnoses was more common in asymptomatic than 
symptomatic smokers (Menezes et al, 2005). However, in 2017 following these studies, 
GOLD asserted that no studies had produced relevant findings on the benefits of screening 
asymptomatic individuals, citing the BOLD study, which is now significantly outdated (Buist 
et al, 2005).  
 
Confusion Regarding Diagnostic Tools 
Perhaps underdiagnoses arise from the methods of screening itself, rather than the 
population screened. Confusion exists among the tools utilised: The recommended 
screening methods for COPD include the use of medical examinations with questionnaires 
(Estes et al, 2017; López Varela, 2016; Siu et al, 2016), to identify relevant risk factors, 
followed by imperative diagnostic spirometry (GOLD, 2017; Kotaki et al, 2017; Delgado et al, 
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2016; López Varela et al, 2016; Roberts, Patel and Partridge, 2016; Celli et al, 2015; Weiss et 
al, 2014; Buist et al, 2007; Levy et al, 2006 cites GOLD, 2001; Menezes et al, 2005). 
Microspirometry with questionnaires may also be utilised as a precursor method for 
spirometry, as both are accessible in primary care settings, without the necessity of 
spirometers (Celli et al, 2015); and are affordable (Dirven et al, 2013; Sichletidis et al, 2011). 
Others promote using peak flow meters (Nelson et al, 2012). Limited access to diagnostic 
tools is often a barrier to diagnosis (Haroon et al, 2015), in addition to cost, time and lack of 
training (Spyratos, Chloros and Sichletidis, 2012). It is integral that nurses know that 
microspirometers must not be used to diagnose COPD, as they result in false diagnoses 
(GOLD, 2017; Gaduzo et al, 2015; NICE, 2011). In addition to precursor tools, nurses must 
undertake a history taking and physical assessment, prior to diagnostic testing (Bragadottir 
et al, 2017; GOLD, 2017; Celli et al, 2015; Roberts, Patel and Partridge, 2016). 
Studies were found incorrectly using hand-held microspirometry to confirm COPD diagnosis 
(Estes et al, 2014). This is not advised in practice, as microspirometers such as the Piko-6® 
often cause an over-estimation of COPD prevalence, and are consequently employed as an 
accurate, sensitive precursor tool, not a diagnostic tool (Frith et al, 2011). In addition, low-
quality diagnostic spirometry can have adverse effects, causing the false positive diagnosis 
of COPD in patients, which leads to unnecessary and harmful treatments, and increased 
healthcare costs (Weiss et al, 2014). Furthermore, as healthcare funds are plummeting, and 
COPD treatment expenses are rising, precise diagnosis is imperious (Spyratos, Chloros and 
Sichletidis, 2012). Therefore, high-quality diagnostic spirometry is fundamental in primary 
care screening. 
 
Correctly Defining Airway Obstruction < can get rid if needs be!! 
Guidelines recommend that three reproducible spirometry readings must be produced 
(van den Bemt et al, 2014), and must meet relevant criterion guidelines (Kotaki et al, 
2017; Roberts, Patel and Partridge, 2016; Celli et al, 2015; Sansores et al, 2013; Levy et al, 
2010), by well-trained staff (Spyratos, Chloros and Sichletidis, 2012). In addition, relevant 
literature states that 400μg of albuterol or salbutamol is the recommended dose for post-
bronchodilator spirometry (van den Bemt et al, 2014; Weiss et al, 2013; Miller et al, 2005). 
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Some studies state that for pre-bronchodilator microspirometry, a fixed cut-off point of 
FEV1/FEV6<0.73 is now preferred over the previous FEV1/FVC<0.70 to indicate airflow 
obstruction in pre-bronchodilator microspirometry (van den Bemt et al, 2014). This was 
suggested due to patients with COPD being missed, as the cut-off point was too low 
(Thorn et al, 2012). However, FEV1 rapidly decreases with age, and FVC does not, so 
therefore this method overestimates the prevalence of COPD, particularly in the elderly 
(Miller et al, 2005), or those with reduced lung growth (Blair and Evelo, 2013); and those 
below 45 years, are often missed (Celli et al, 2015). Despite the benefits of FEV1/FVC <0.7 
as a straightforward cut-off point, it is not dynamic unlike the Lower Limit of Normal 
(LLN) of FEV1/FVC.  
LLN is the favoured ‘gold standard’ over FEV1/FVC to diagnose COPD with spirometry, as 
it considers demographic variables (Csikesz and Gartman, 2014). However, patients are 
likewise often missed with LLN criteria (Celli et al, 2015 cite Bhatt et al, 2014; Sansores et 
al, 2013). Unclarity remains regarding cut-off points, yet COPD requires greater precision to 
diagnose than other diseases (Weiss et al, 2014). Nurses play an important role in the early 
diagnosis of COPD (Blair and Evelo, 2013), yet COPD screening rates remain low (Blair and 
Evelo, 2013; Sansores et al, 2013), which leads to COPD underdiagnoses (Weiss et al, 
2014; Schirnhofer et al, 2007). Therefore, both research surrounding COPD screening, and 
nursing training needs to significantly improve to combat COPD underdiagnoses. 
 
The Need for COPD Education 
During the critical appraisal of literature and thematic analysis, it became apparent that 
education surrounding COPD was a necessary requirement not just for patients, but for 
practitioners and wider society. Nurses and the public must be made aware of the 
symptoms of COPD, to enable early detection (Suthar, Patel and Shah, 2015). Sansores et al 
(2013) identified the most common symptoms to be cough (p=0.01), dyspnoea (p<0.001) 
and wheezing (p=0.01). Despite symptoms being frequently present (Kotaki et al, 2017; 
Delgado et al, 2016; Roberts, Patel and Partridge, 2016; Estes et al, 2014; Weiss et al, 2014; 
Sansores et al, 2013), patients often adjust to symptoms, and do not accept the existence of 
their disease (Bragadottir et al, 2017). Bragadottir et al’s (2017) study was a pioneer study of 
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the feelings and challenges patients and families face in relation to COPD. In Japan, patients 
commonly mistook the symptoms of COPD for natural ageing (Kotaki et al, 2017). Patients, 
professionals and the public need to be made aware of the risk factors, such as air pollution 
(Kotaki et al, 2017), indoor pollution (GOLD, 2017) and smoking (Spyratos, Chloros and 
Sichletidis, 2012).  
Education needs to be improved in other aspects. Professionals commonly incorrectly 
diagnose patients with asthma, therefore triggering a requirement to distinguish between 
the two diseases (Koblizek et al, 2016; Weiss et al, 2014). In many studies, an incorrect dose 
of bronchodilator pre-spirometry caused asthmatics to be diagnosed with COPD (Weiss et 
al, 2014; Buist et al, 2007; Menezes et al, 2005). Weiss et al (2014) state that the awareness 
of COPD needs to be heightened in both patients and professionals, as poor knowledge and 
expertise are significant barriers to diagnosis (Haroon et al, 2015). Therefore, if education 
improves, the number of patients underdiagnosed will also (Koblizek et al, 2016). 
Furthermore, to combat underdiagnoses further, accurate and reliable spirometry readings 
are a necessity to achieve, which requires thorough training (Koblizek et al, 2016). 
 
Practice Nurses at the Heart of COPD Screening 
Some nurses are more aware of COPD than others depending upon speciality. Blair and 
Evelo (2013) discovered that family nurse practitioners were more likely to screen for COPD 
risk factors than other ‘population-specific’ (women's health, paediatric, and geriatric) nurse 
practitioners. In the UK, primary care professionals are in an ideal position to detect COPD 
(Koblizek et al, 2016). However, Weiss et al (2014) discovered that GPs need to improve 
their medical education, to improve their support for COPD detection. Professionals must be 
trained and competent themselves, to be able to perform comprehensive patient 
assessments (Baxter et al, 2016). However, other studies state that primary care providers 
are most aware of COPD (Blair and Evelo, 2013). Yet, COPD is regularly underdiagnosed 
(Koblizek et al, 2016; Jones et al, 2014; Weiss et al, 2014; NICE 2016; Schirnhofer et al, 
2007). A reason for this, may be that nurses do not always apply their knowledge to clinical 
practice (Blair and Evelo, 2013; Sansores et al, 2013). 
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Patient Education 
If primary care professionals are more aware of COPD than others, why is COPD regularly 
undiagnosed in the UK? Perhaps the answer lies with public health awareness and patients, 
not healthcare professionals. A study has found that patients are reluctant to seek advice 
from their primary care provider, regarding any respiratory difficulties (Bragadottir et al, 
2017; Weiss et al, 2014). This is frequently due to their adaptation to respiratory symptoms, 
or a lack of awareness of the disease (Suthar, Patel and Shah, 2015). Therefore, patients 
need to receive increased education, such as the obligation to quit smoking early on 
(Koblizek et al, 2016). Although Bragadottir et al (2017) study it incorporated relatives’ 
understanding, which are likely to show similarities with the publics’ views. This study found 
that patients and their relatives lacked awareness of COPD. Therefore, connoting that 
widespread public health education is an effective intervention for the prevention, 
management and understanding of COPD (Centers for Disease Control and Prevention, 
2011). 
 
Improving Public Health Awareness 
Patients also asserted the need for increased public awareness (Bragadottir et al, 2017), the 
benefits are: reduced stigma, as COPD is often perceived to be ‘self-inflected’; increased 
education, as sufferers often hide the disease as it is not recognised within society; 
increased awareness of the harms of smoking, benefits of cessation, and the need for 
screening; and lastly, the everyday challenge those with COPD face. Society’s attitudes 
towards COPD need to be investigated, to advise forthcoming education, and create 
strategies that increase awareness (Haroon et al, 2015). Society is often unaware of the 
severity COPD imposes upon life, and frequently judge those who have it (Bragadottir et al, 
2017). An improvement in public health awareness enhances education regarding risk 
factors, smoking cessation, and enables interventions to be achieved (Centers for Disease 
Control and Prevention, 2011). 
 
Discussion 
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The purpose of this study was to discover the factors preventing the early diagnosis of 
COPD. In addition, the aim was to explore the role of early screening of COPD, as a means of 
combatting underdiagnoses. As a result, main findings arose to the surface: there is a 
requirement of increased education for both healthcare providers and patients. Moreover, 
there remains a conflict between case finding versus screening strategies within healthcare. 
Within the respiratory field, the prevalence of COPD amongst women is on the rise, yet 
gender inequalities still exist. The above factors contribute to the underdiagnoses of COPD 
today. 
During the thematic analysis, a correlation between the factors emerged. Spirometry 
screening is required for diagnosis, but it cannot be undertaken in the absence of education. 
Nurses must be aware of the symptoms and risk factors, but also how to accurately 
diagnose COPD. Furthermore, gender is also interlinked, as nurses must be aware of the 
gender inequalities that lead to late diagnosis in women, due to stigmatisation of 
psychosomatic illness (Delgado et al, 2016; Modica et al, 2014). An overarching element that 
appeared following the thematic analysis, was ‘stigma’. Patients are reluctant to seek 
medical advice due to perceived stigma from professionals (Bragadottir et al, 2017). 
To combat COPD underdiagnoses, we need to target patients in both primary care and 
through public awareness. In addition, women need to know that they are more susceptible 
to the harms of smoking (GOLD, 2017; Blair and Evelo, 2013), consecutively with research 
undertaken to determine why this susceptibility exists. Is it due to the pathophysiological 
make-up of women? Studies suggest that female hormones impact susceptibility, others 
state there is a genetic trend (Jenkins et al, 2017). Although the answer is not clear, the 
drastic increase in prevalence of COPD needs to be ceased. This can only be achieved by 
early diagnosis of COPD, and cannot be achieved by case-finding alone. Only 85% Of COPD 
in women is caused by smoking (Blair and Evelo, 2013 cite Cote and Chapman, 2009), and 
even then, patients will not necessarily be symptomatic (Kathirvel Senthilnathan et al, 2016; 
Wisnivesky et al, 2014). No public health material exists today specifically targeting the 
female population, so the responsibility falls to nurses, to educate their patients. 
Quality of care may be improved through the introduction of broad COPD screening. This 
method not only identifies women with COPD who have been missed, but men also 
(Wisnivesky et al, 2014; Sansores et al, 2013; Menezes et al, 2005). In addition, these 
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patients may be asymptomatic (Kathirvel Senthilnathan et al, 2016; Wisnivesky et al, 2014). 
Therefore, case-finding is unlikely to identify these patients, and although it is a cost-
effective method, the implementation of screening needs to be considered. Further 
research must be must be undertaken to compare the two methods, and to find a way of 
implementing screening to find those undiagnosed, who with case-finding, would have 
otherwise been missed. Moreover, research needs to be conducted to identify screening 
methods that are affordable, and can be performed in primary care within availability of 
staff and resources. 
In primary care, nurses and GPs are in a prime position to identify those with COPD, so why 
are diagnostic rates so low? As identified in the literature review, many professionals are 
incorrectly diagnosing patients with asthma (Koblizek et al, 2016; Weiss et al, 2014; Buist et 
al, 2007; Menezes et al, 2005), or employing inefficient diagnostic tools, such as 
microspirometry (Estes et al, 2017). Diagnostic spirometry is expensive to purchase, yet 
questionnaires and microspirometers are not (Dirven et al, 2013). So why are precursor 
tools not being utilised in primary care? Some studies state those in primary care are 
exceptionally aware of COPD, and utilise precursor tools (Roberts, Patel and Partridge, 2016; 
Blair and Evelo, 2013). Therefore, perhaps the accountability lies elsewhere.  
It may be suggested that COPD underdiagnoses lie with the fault of significant organisations, 
who are not aware of the true impact early diagnosis would produce. COPD costs the NHS 
£1.9 billion per year (British Lung Foundation, 2017), and in the UK, 25,000 people lose their 
lives annually (Health and Safety Executive, 2016). As one of the biggest killers, which is 
predicted to be the third largest by 2020 (GOLD, 2017; Kotaki et al, 2017; Weiss et al, 2014; 
Wisnivesky et al, 2014; Blair and Evelo, 2013), change in the current identification needs to 
be achieved. Once this is addressed, the prevalence of underdiagnoses, rates of lung decline 
in patients, quality of life, and financial impact upon health care systems, will all significantly 
improve (Csikesz and Gartman, 2014). A healthcare system that provides this, will ultimately 
improve patient care. COPD will be caught earlier, which will improve the effectiveness of 
interventions and disease management (Wisnivesky et al, 2014). Although there is evidence 
that COPD identification methods are moving towards a more generalised screening 
(Gaduzo et al, 2015; Wisnivesky et al, 2014; Sansores et al, 2013), little research exists to 
support this, and therefore needs to be undertaken. Research needs to particularly focus on 
14 
 
screening methods in primary care that will identify a higher number of COPD cases, to 
reduce the global burden of the disease. 
Community Pharmacists are in a prime position to identify patients with COPD through early 
case-finding. Pharmacists are regularly the first port-of-call for patients expressing signs of 
COPD such as breathlessness, risk factors such as smoking, and are able to screen patients at 
risk (van der Molen et al, 2017). 
Many UK guidelines are significantly outdated, and GOLD (2017) state that no studies 
pertaining to early screening exist, and fail to identify a necessity for these studies to be 
undertaken. However, Gaduzo et al, (2015) identified that the two million patients with 
undiagnosed COPD may benefit from screening, but there is a current lack of research and 
agreement regarding the benefits of screening versus case-finding. Still, on the other hand, 
the 2011-2016 NICE guidelines do not cover “COPD prevention, screening or case finding”. 
Yet, NICE are responsible for providing evidence-based guidance to the NHS (NICE 2017). 
Therefore, the NICE (2011) guidelines are a barrier to the early diagnosis of COPD, as they 
do not outline screening and case-finding guidance. In 2013, the UK National Screening 
Committee (UK NSC) stated that “a screening programme for COPD is not recommended at 
this time” (p.1). Yet, there is no information to state whether this guidance still exists, four 
years later. The authors themselves suggest that screening may be a useful intervention to 
identify COPD early-on in patients, and enable early treatment and interventions. Key 
organisations such as NICE and GOLD are in a prime position to be ‘opinion leaders’; to 
enable the implementation and diffusion of ‘early generalised screening’ through primary 
care (Rogers, 2003). However, this cannot be done until thorough research is undertaken. 
 
Recommendations 
1. Further research must be done to compare the benefits of screening versus case-
finding, to identify those with COPD who are asymptomatic; discover a method that 
is cost-effective, and diagnoses the ‘missing millions’ (Gaduzo et al, 2015) 
2. Increase the training and education of nursing and allied healthcare professionals, 
regarding: COPD; screening with questionnaires and microspirometry; signs and 
symptoms; risk factors; diagnostic testing with spirometry 
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3. Professionals worldwide must be made of the necessity of spirometry to diagnose 
COPD, as outlined by GOLD (2017), and the ability of questionnaires and 
microspirometers as pre-cursor tools 
4. Improvements in guidelines produced by the key organisations, are integral for a 
widespread change in early detection; particularly by diffusion of ideas (Rogers, 
2003) 
 
 
Overarching Recommendation 
To undertake a large-scale, global study comparing case-finding with generalised screening, 
for the early detection of undiagnosed COPD. 
 
Conclusion 
The purpose of the review was to consider factors influencing early COPD screening, within 
primary care. Although there is a significant lack in evidence (GOLD ,2017), it is suggested 
that screening may have a greater opportunity to identify those who would have otherwise 
been missed (Sansores et al, 2013), despite GOLD (2018) stating that the yield of COPD 
diagnosis is sufficiently high. Although Sansores et al’s study was limited, it is moving in the 
direction of improving early diagnosis, to identify patients before they reach moderate 
COPD (GOLD, 2017). Ultimately, although it is suggested that spirometry screening for COPD 
should be employed globally as an assessment tool (GOLD 2018), there is a lack of evidence 
to support this, and therefore, evidence must be produced. Nurses in primary care are in 
the best position to implement early screening (Weiss et al, 2013), but education, and 
accurate spirometry are integral to this role.  
 
 
Tables  
Table 1  
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First 
Author 
Purpose of Study Findings Statistical 
Significance of 
Findings 
van den 
Bemt 
To determine the diagnostic accuracy of pre-
bronchodilator (BD) FEV1/FEV6 ratio from 
microspirometry, relative to a post-BD 
FEV1/FEV6 ratio from diagnostic spirometry. 
The patients were referred for spirometry by 
their GPs because of respiratory symptoms 
indicative of COPD. 
A subject with a negative microspirometry test 
was unlikely to show airflow obstruction in a 
subsequent diagnostic spirometry. 
Microspirometry does not accurately diagnose 
COPD. 
Statistically 
significant (SS) 
Blair Primary purpose: “Discuss risk factors for 
COPD and identify at-risk populations”; in 
relation to the speciality the NPs work within. 
Secondary purpose: “To report the findings of 
a recent survey of nurse practitioners (NPs) in 
Colorado regarding their knowledge about the 
risk factors of COPD” (p.123). 
As hypothesised, parametric results reported that 
‘population-specific NPs’ (paediatric, 
gerontological, and women’s health NPs) 
identified less risk factors for COPD than both 
family NPs and adult NPs. 
Not statistically 
significant (NSS) 
Wisnivesky To investigate the prevalence of COPD, 
characterised by airflow obstruction in 
spirometry in a group of asymptomatic 
smokers (5 or more years) with no history of 
asthma, COPD or respiratory symptoms; and 
to identify risk factors of abnormal spirometry. 
The prevalence of undiagnosed airway 
obstruction in this population was 2.3%, 
therefore suggesting it is possible to diagnose 
asymptomatic smokers with airway obstruction. 
However, further research needs to be 
performed into the benefits of early diagnosis 
and cost-effectiveness of screening. 
NSS 
Bragadottir To describe the lived experience of both 
patients and their relatives following a COPD 
diagnosis. The authors’ main aims were to 
decipher: a greater understanding of shame, 
the course of events as COPD manifests itself 
in the participants’ life, especially the 
experience of receiving the diagnosis itself, 
and the obstacles the patients and families 
face. 
The researchers identified five themes: 
1. ‘Burden of shame and self-blame’: 
participants believed COPD was 
brought on by themselves yet 
participants felt disdain towards 
people who believe smoking caused 
their COPD. 
2. ‘Enclosed in addiction’: Nicotine 
addiction was found at the core of the 
participants’ experiences, yet patients 
struggled to name and face the 
addiction. 
3. ‘Living in parallel worlds’: patients 
would often hide their COPD from 
themselves and others 
4. ‘Realising the existence of the 
disease’: Patients struggled to 
acknowledge the existence of the 
disease despite warning signs of 
progression 
5. ‘A cry for empathy’: Patients and their 
relatives both expressed a lack of 
understanding from friends, family 
and society, and assert the need for 
public health awareness on COPD 
^shall I cut the above down and make it 
brief? 
N/A 
Weiss To evaluate COPD prevalence in the over- 40 
years population, and compare the detection 
strategies for COPD in primary-care settings 
(GP surgeries). 
7.5% of participants has FEV1/FVC<0.7 and 
FEV1<80% of predicted, indicating a COPD 
diagnosis of grade II+; however, only 22.4% of 
these patients had a previous diagnosis of COPD, 
indicating that COPD is widely underdiagnosed. 
The low participation rate of both GPs and 
patients signposts that COPD healthcare and 
public health awareness needs to be vastly 
improved. 
COPD requires greater precision to diagnose than 
other chronic diseases.  
SS 
Sansores The authors found a gap in knowledge when 
doing their literature search: that additional 
information is needed concerning the 
usefulness of spirometry when smokers are 
not selected based on respiratory symptoms. 
This is the first study to simultaneously 
compare both diagnostic strategies. To study 
this, the researchers compared two 
Prevalence of COPD was 10.1% for the case-
finding strategy and 13.3% for the smoking 
cessation programme strategy (SCS) (p<0.01). 
According to LLN, the screening group was higher 
than the case-finding group. The authors suggest 
these results are due to the greater prevalence of 
smoking in the screening group (pack/years). The 
authors analysed the results using a multivariate 
1999 
participants 
were analysed 
for the case-
finding strategy 
versus 782 
participants 
screening 
17 
 
populations to determine which technique is 
more effective at diagnosing COPD early: 
symptomatic smokers (the presence of 
respiratory symptoms) undergoing spirometry 
(case-finding), versus a screening programme 
during a smoking cessation clinic (spirometry 
was undergone as part of a medical 
evaluation). 
An additional objective was to determine the 
predictive value of respiratory symptoms to 
encourage an early diagnosis of COPD. 
logistic regression analysis which found that 
dyspnoea was the only common predictor of 
COPD in both samples. Risk factors for COPD 
were: male gender (p<0.001), cough (p=0.01), 
dyspnoea (p<0.001), wheezing (p=0.01) and age 
(being older) (p<0.001). However, age may be 
due to the natural decline in lung function that is 
associated with ageing (Quanjer et al. 2012). 
 
(2.56:1 ratio). It 
is difficult to 
generalise the 
results when 
the difference in 
sample 
populations is 
so vast (Elsevier 
2017). 
 
Roberts The purpose of the study was to compare 
which biases encourage GPs to refer patients 
for suspected COPD in men, versus women. 
Significant statistical differences in the 
confirmation of ‘correct’ COPD diagnoses were: 
men=72% and women=56% (p=0.001). 
A ‘definite COPD’ diagnosis was confirmed 
significantly more frequently in men than women 
(87.5% and 73.9% respectively, (p=0.021, n=180)).  
A ‘suspected COPD’ diagnosis was confirmed 
more frequently in men also: 60.9% of men and 
43.2% of women (p=0.004, n=265). 
Therefore, men were more likely to have COPD 
suspected by their GP, and a confirmed diagnosis. 
Women however, were more likely to report 
allergies (30.4%=women vs 17.0%=men 
(p=0.099), but not significantly different), but less 
likely to report breathlessness as their main 
symptom. 
SS 
Delgado To analyse decision-making in primary care for 
men and women with identical COPD as a 
function of the gender of the family physician 
(FP). 
Smoking was identified as the most prominent 
risk factor for males, by both female (95.6% vs 
67.1%) and male FPs (79.8% vs 62.5%). In 
addition, men were more likely to be suspected 
of COPD than women, by both the female (84.4% 
vs 49.9%) and male (78.5% vs 57.8%) FPs. The FPs 
were more likely to diagnose COPD if the vignette 
was a man (34.5% higher when the FP was 
female, 20.7% higher when the FP was male). This 
supports that women usually receive a delay in 
COPD diagnosis, and that COPD is regularly 
underdiagnosed in women. It is therefore 
confirmed that gender is a variable that 
influences characteristic for diagnostic behaviour. 
SS 
Kotaki To evaluate the effectiveness of a cooperative 
healthcare model for early detection and 
diagnosis in COPD. The purpose of this study 
was to improve the early management of 
COPD through early detection. 
30/293 patients were suspected of moderate 
COPD. Between the suspected COPD and non-
suspected COPD groups, there were many 
differences in symptoms. COPD prevalence was 
highest in smokers (21%), followed by the ex-
smokers (13%), passive smokers (7%) and non-
smokers (7%). Of the 6 patients with suspected 
COPD, only 2 were diagnosed with COPD.  
The pollution concentrations were higher for 
Õmuta on average compared to Japan in both 
2012 and 2013. The authors have suggested that 
therefore their study found a higher prevalence 
of COPD in one region (Õmuta), in comparison to 
a NICE study of all Japanese regions (Fukuchi et 
al. 2004). Those with COPD had lower FVC, %VC, 
FEV1, FEV1/FVC readings (all p<0.00). 
SS 
Estes To undertake a case-finding program for 
COPD, in a community clinic that was not 
screening for COPD. 
In total, 27/39 patients (69%) had a spirometry 
reading and COPD Questionnaire outcome that 
agreed (i.e. both positive or both negative for 
COPD). Therefore in 12/39 patients (31%) the 
microspirometry and questionnaire outcomes 
disagreed. This indicates that microspirometry 
and the COPD Questionnaire were over 
estimating the prevalence of COPD, with 10 false 
positives in comparison to only 2 true positives. 
10% of the sample had COPD (4/39): All 4 
patients with COPD had GOLD type II (moderate 
COPD). 2 patients were ‘true positives’, 2 patients 
were ‘false negatives’. 
NSS 
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Further Reading and Useful Information 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2018). Global Strategy for 
the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2018 
Report). http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-
20-Nov_WMS.pdf (accessed 15 Mar 2018) 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2017) Global Strategy for 
the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary 
Disease. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-
copd/ (accessed 4 July 2017) 
 
Sansores RH, Ramírez-Venegas A, Hernández-Zenteno R, Mayar-Maya ME, Pérez-Bautista 
OG, Velázquez Uncal M (2013) Prevalence and Diagnosis of Chronic Obstructive Pulmonary 
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Appendices 
Appendix 1 - GOLD COPD Grading 
 
Taken from: The Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2017. Global 
Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary 
Disease. [Ebook] Global Initiative for Chronic Obstructive Lung Disease. Available from: 
http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/ [4 
July 2017]. 
 
 
 
